Juniper Investment Company, LLC filed a Form 4 with the SEC on September 22, 2026, reporting two open-market purchases of Orthofix Medical Inc. common stock by Juniper Targeted Opportunity Fund, L.P. on September 18 and September 21, 2026.

Key Highlights

  • First transaction: 120,000 shares of Orthofix Medical common stock acquired on September 18, 2026, at a weighted average price of $8.7393 per share, with a range from $8.65 to $8.81.
  • Second transaction: 190,000 shares acquired on September 21, 2026, at a weighted average price of $8.8599 per share, with a range from $8.63 to $8.98.
  • Post-transaction holdings: Juniper Targeted Opportunity Fund, L.P. held 3,771,216 shares indirectly following the September 21 transaction.
  • Additional holdings: Juniper Multi-Strategy Fund, L.P. held 84,926 shares and Juniper Targeted Opportunities, L.P. held 935,901 shares, each indirectly through Juniper Investment Company.
  • Reporting persons: Juniper Investment Company, LLC, John A. Bartholdson, and Alexis P. Michas, all listed as 10% owners and directors of Orthofix Medical Inc.
  • Transaction codes: Both transactions are coded "S" in the filing, representing open-market sales entries under the acquisition column marked "A."

Juniper Investment Company Adds to Orthofix Medical Position Across Two Trading Days

According to the filing, Juniper Investment Company, LLC reported two purchases of Orthofix Medical Inc. (NASDAQ:OFIX) common stock, $0.10 par value per share, executed through Juniper Targeted Opportunity Fund, L.P. On September 18, 2026, 120,000 shares were acquired at a weighted average price of $8.7393, within a range of $8.65 to $8.81 per share. On September 21, 2026, an additional 190,000 shares were acquired at a weighted average price of $8.8599, within a range of $8.63 to $8.98 per share. The filing notes that the reporting person will provide individual trade details to the issuer or the SEC upon request.

Following these transactions, the filing reports that Juniper Targeted Opportunity Fund, L.P. indirectly held 3,771,216 shares. Separately, Juniper Multi-Strategy Fund, L.P. held 84,926 shares and Juniper Targeted Opportunities, L.P. held 935,901 shares, both indirectly through Juniper Investment Company, LLC as investment manager. The filing states that Juniper Investment Company disclaims beneficial ownership of all interests reported except to the extent of its pecuniary interest.

The filing identifies John A. Bartholdson and Alexis P. Michas as managing members of Juniper Investment Company and general partners of each of the three Juniper funds. According to the filing, Bartholdson and Michas share voting and dispositive power over the reported shares with Juniper Investment Company, and each individually disclaims beneficial ownership except to the extent of their respective pecuniary interests. All three reporting persons are listed as both directors and 10% owners of Orthofix Medical Inc.

What Was Disclosed

Juniper Investment Company, LLC, along with John A. Bartholdson and Alexis P. Michas, reported the acquisition of a combined 310,000 shares of Orthofix Medical Inc. common stock across two trading days, held indirectly through Juniper Targeted Opportunity Fund, L.P., with total indirect holdings across affiliated funds exceeding 4.7 million shares.